Explore

Trendline Trendline
Pomerantz Law Firm Files Class Action Against Graphic Packaging Holding Company Over Securities Violations

Pomerantz Law Firm Files Class Action Against Graphic Packaging Holding Company Over Securities Violations

Pomerantz Law Firm Files Class Action Against Graphic Packaging Holding Company Over Securities Violations
Trendline Trendline
Pomerantz Law Firm Investigates Gaia, Inc. for Potential Securities Fraud

Pomerantz Law Firm Investigates Gaia, Inc. for Potential Securities Fraud

Pomerantz Law Firm Investigates Gaia, Inc. for Potential Securities Fraud
Trendline Trendline
Robbins Geller Investigates Via Transportation for Potential Securities Law Violations

Robbins Geller Investigates Via Transportation for Potential Securities Law Violations

Robbins Geller Investigates Via Transportation for Potential Securities Law Violations
Trendline Trendline
FDA Approves BeOne's Beqalzi for Mantle Cell Lymphoma, Expanding Treatment Options

FDA Approves BeOne's Beqalzi for Mantle Cell Lymphoma, Expanding Treatment Options

FDA Approves BeOne's Beqalzi for Mantle Cell Lymphoma, Expanding Treatment Options
Trendline Trendline
Robbins Geller Rudman Dowd LLP Launches Investigation into Via Transportation for Potential Securities Violations

Robbins Geller Rudman Dowd LLP Launches Investigation into Via Transportation for Potential Securities Violations

Robbins Geller Rudman Dowd LLP Launches Investigation into Via Transportation for Potential Securities Violations
Trendline Trendline
Immunome Advances Oncology Pipeline with New Drug Application and Clinical Trials

Immunome Advances Oncology Pipeline with New Drug Application and Clinical Trials

Immunome Advances Oncology Pipeline with New Drug Application and Clinical Trials
Trendline Trendline
Pomerantz Law Firm Investigates B Foods for Potential Securities Fraud Amid Dividend Cut

Pomerantz Law Firm Investigates B Foods for Potential Securities Fraud Amid Dividend Cut

Pomerantz Law Firm Investigates B Foods for Potential Securities Fraud Amid Dividend Cut
Trendline Trendline
INOVIO Reports First Quarter 2026 Financial Results Amid Regulatory Review of INO-3107

INOVIO Reports First Quarter 2026 Financial Results Amid Regulatory Review of INO-3107

INOVIO Reports First Quarter 2026 Financial Results Amid Regulatory Review of INO-3107
Trendline Trendline
Pomerantz Law Firm Investigates Rocky Brands for Potential Securities Fraud

Pomerantz Law Firm Investigates Rocky Brands for Potential Securities Fraud

Pomerantz Law Firm Investigates Rocky Brands for Potential Securities Fraud
Trendline Trendline
Pomerantz Law Firm Investigates MiMedx Group for Potential Securities Fraud

Pomerantz Law Firm Investigates MiMedx Group for Potential Securities Fraud

Pomerantz Law Firm Investigates MiMedx Group for Potential Securities Fraud
Trendline Trendline
Pomerantz Law Firm Investigates Ducommun Inc. for Potential Securities Fraud

Pomerantz Law Firm Investigates Ducommun Inc. for Potential Securities Fraud

Pomerantz Law Firm Investigates Ducommun Inc. for Potential Securities Fraud
Trendline Trendline
Medpace Faces Securities Fraud Class Action Following Stock Plunge

Medpace Faces Securities Fraud Class Action Following Stock Plunge

Medpace Faces Securities Fraud Class Action Following Stock Plunge